INS and type 2 diabetes mellitus: This topic has been addressed in a number of randomised controlled trials that have evaluated the administration of DPPIVi in previously DPPIVi-naïve patients with type 2 diabetes who were poorly controlled on basal insulin therapy [8, 10].